Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...

An Australian research team conducted a year-long longitudinal study of medical cannabis treatments for chronic pain patients ...

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Around the world, the debate continues about how to quantify the presence of cannabis in an individual’s system and how it ...

Medicinal cannabis users in Victoria will no longer automatically lose their licence if caught driving with traces of the ...

Veterans are being targeted by social media ads offering access to "free" medicinal cannabis, funded by the Department of ...

Inc. (TSX: ACB) reported strong results in its fiscal Q2 2025 earnings, posting a 29% year-over-year increase in total revenue, reaching $81.1 million compared to $63.1 million in ...

The first drive has taken place on the Victoria Government's closed-circuit trial to investigate whether individuals who use ...

Medicinal cannabis users will no longer lose their licence automatically if they test positive on roadside drug tests in a ...